ADC Therapeutics SA (ADCT)
Total Valuation
ADCT has a market cap or net worth of $147.81 million. The enterprise value is -$39.07 million.
| Market Cap | 147.81M |
| Enterprise Value | -39.07M |
Important Dates
The next estimated earnings date is Tuesday, February 27, 2024, before market open.
| Earnings Date | Feb 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 89.04 million shares outstanding. The number of shares has increased by 5.93% in one year.
| Shares Outstanding | 89.04M |
| Shares Change (YoY) | +5.93% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 32.61% |
| Owned by Institutions (%) | 52.31% |
| Float | 51.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| Forward PS | 1.92 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.80
| Current Ratio | 4.80 |
| Quick Ratio | 4.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.88 |
Financial Efficiency
Return on equity (ROE) is -1,121.90% and return on invested capital (ROIC) is -201.16%.
| Return on Equity (ROE) | -1,121.90% |
| Return on Assets (ROA) | -36.20% |
| Return on Capital (ROIC) | -201.16% |
| Revenue Per Employee | $386,644 |
| Profits Per Employee | -$563,114 |
| Employee Count | 317 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 0.14 |
Taxes
| Income Tax | -2.99M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.20% in the last 52 weeks. The beta is 1.24, so ADCT's price volatility has been higher than the market average.
| Beta (1Y) | 1.24 |
| 52-Week Price Change | -56.20% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 64.88 |
| Average Volume (30 Days) | 532,262 |
Short Selling Information
The latest short interest is 4.05 million, so 4.55% of the outstanding shares have been sold short.
| Short Interest | 4.05M |
| Short Previous Month | 3.62M |
| Short % of Shares Out | 4.55% |
| Short % of Float | 7.88% |
| Short Ratio (days to cover) | 5.11 |
Income Statement
In the last 12 months, ADCT had revenue of $122.57 million and -$178.51 million in losses. Loss per share was -$2.19.
| Revenue | 122.57M |
| Gross Profit | 119.80M |
| Operating Income | -139.50M |
| Pretax Income | -181.50M |
| Net Income | -178.51M |
| EBITDA | -131.90M |
| EBIT | -134.73M |
| Loss Per Share | -$2.19 |
Balance Sheet
The company has $310.41 million in cash and $123.53 million in debt, giving a net cash position of $186.88 million or $2.10 per share.
| Cash & Cash Equivalents | 310.41M |
| Total Debt | 123.53M |
| Net Cash | 186.88M |
| Net Cash Per Share | $2.10 |
| Equity / Book Value | -54.18M |
| Book Value Per Share | -0.61 |
| Working Capital | 297.39M |
Cash Flow
In the last 12 months, operating cash flow was -$122.10 million and capital expenditures -$1.29 million, giving a free cash flow of -$123.38 million.
| Operating Cash Flow | -122.10M |
| Capital Expenditures | -1.29M |
| Free Cash Flow | -123.38M |
| FCF Per Share | -$1.51 |
Margins
Gross margin is 97.74%, with operating and profit margins of -113.82% and -145.64%.
| Gross Margin | 97.74% |
| Operating Margin | -113.82% |
| Pretax Margin | -148.08% |
| Profit Margin | -145.64% |
| EBITDA Margin | -107.62% |
| EBIT Margin | -109.93% |
| FCF Margin | -100.67% |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -120.77% |
| FCF Yield | -83.47% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.93% |
| Shareholder Yield | -5.93% |
Analyst Forecast
The average price target for ADCT is $4.20, which is 153.01% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.20 |
| Price Target Difference | 153.01% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 7.88% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -3.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.46 |
| Piotroski F-Score | 2 |